table of content
1 Introduction to Research & Analysis Reports
1.1 Gene Therapies for Cancer Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene Therapies for Cancer Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene Therapies for Cancer Treatment Overall Market Size
2.1 Global Gene Therapies for Cancer Treatment Market Size: 2021 VS 2028
2.2 Global Gene Therapies for Cancer Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene Therapies for Cancer Treatment Players in Global Market
3.2 Top Global Gene Therapies for Cancer Treatment Companies Ranked by Revenue
3.3 Global Gene Therapies for Cancer Treatment Revenue by Companies
3.4 Top 3 and Top 5 Gene Therapies for Cancer Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Gene Therapies for Cancer Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Therapies for Cancer Treatment Players in Global Market
3.6.1 List of Global Tier 1 Gene Therapies for Cancer Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene Therapies for Cancer Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Gene Therapies for Cancer Treatment Market Size Markets, 2021 & 2028
4.1.2 Somatic Cell Gene Therapy (SCGT)
4.1.3 Germline Gene Therapy (GGT)
4.2 By Type - Global Gene Therapies for Cancer Treatment Revenue & Forecasts
4.2.1 By Type - Global Gene Therapies for Cancer Treatment Revenue, 2017-2022
4.2.2 By Type - Global Gene Therapies for Cancer Treatment Revenue, 2023-2028
4.2.3 By Type - Global Gene Therapies for Cancer Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene Therapies for Cancer Treatment Market Size, 2021 & 2028
5.1.2 Cancer Research Centers
5.1.3 Diagnostic Laboratories
5.1.4 Cancer Hospitals
5.1.5 Others
5.2 By Application - Global Gene Therapies for Cancer Treatment Revenue & Forecasts
5.2.1 By Application - Global Gene Therapies for Cancer Treatment Revenue, 2017-2022
5.2.2 By Application - Global Gene Therapies for Cancer Treatment Revenue, 2023-2028
5.2.3 By Application - Global Gene Therapies for Cancer Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Gene Therapies for Cancer Treatment Market Size, 2021 & 2028
6.2 By Region - Global Gene Therapies for Cancer Treatment Revenue & Forecasts
6.2.1 By Region - Global Gene Therapies for Cancer Treatment Revenue, 2017-2022
6.2.2 By Region - Global Gene Therapies for Cancer Treatment Revenue, 2023-2028
6.2.3 By Region - Global Gene Therapies for Cancer Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Gene Therapies for Cancer Treatment Revenue, 2017-2028
6.3.2 US Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.3.3 Canada Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.3.4 Mexico Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Gene Therapies for Cancer Treatment Revenue, 2017-2028
6.4.2 Germany Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.4.3 France Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.4.4 U.K. Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.4.5 Italy Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.4.6 Russia Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.4.8 Benelux Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Gene Therapies for Cancer Treatment Revenue, 2017-2028
6.5.2 China Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.5.3 Japan Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.5.4 South Korea Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.5.6 India Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Gene Therapies for Cancer Treatment Revenue, 2017-2028
6.6.2 Brazil Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.6.3 Argentina Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gene Therapies for Cancer Treatment Revenue, 2017-2028
6.7.2 Turkey Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.7.3 Israel Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Gene Therapies for Cancer Treatment Market Size, 2017-2028
6.7.5 UAE Gene Therapies for Cancer Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Takara Bio
7.1.1 Takara Bio Corporate Summary
7.1.2 Takara Bio Business Overview
7.1.3 Takara Bio Gene Therapies for Cancer Treatment Major Product Offerings
7.1.4 Takara Bio Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.1.5 Takara Bio Key News
7.2 Tocagen
7.2.1 Tocagen Corporate Summary
7.2.2 Tocagen Business Overview
7.2.3 Tocagen Gene Therapies for Cancer Treatment Major Product Offerings
7.2.4 Tocagen Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.2.5 Tocagen Key News
7.3 VBL Therapeutics
7.3.1 VBL Therapeutics Corporate Summary
7.3.2 VBL Therapeutics Business Overview
7.3.3 VBL Therapeutics Gene Therapies for Cancer Treatment Major Product Offerings
7.3.4 VBL Therapeutics Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.3.5 VBL Therapeutics Key News
7.4 Cold Genesys
7.4.1 Cold Genesys Corporate Summary
7.4.2 Cold Genesys Business Overview
7.4.3 Cold Genesys Gene Therapies for Cancer Treatment Major Product Offerings
7.4.4 Cold Genesys Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.4.5 Cold Genesys Key News
7.5 Genprex
7.5.1 Genprex Corporate Summary
7.5.2 Genprex Business Overview
7.5.3 Genprex Gene Therapies for Cancer Treatment Major Product Offerings
7.5.4 Genprex Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.5.5 Genprex Key News
7.6 Momotaro-Gene
7.6.1 Momotaro-Gene Corporate Summary
7.6.2 Momotaro-Gene Business Overview
7.6.3 Momotaro-Gene Gene Therapies for Cancer Treatment Major Product Offerings
7.6.4 Momotaro-Gene Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.6.5 Momotaro-Gene Key News
7.7 MultiVir
7.7.1 MultiVir Corporate Summary
7.7.2 MultiVir Business Overview
7.7.3 MultiVir Gene Therapies for Cancer Treatment Major Product Offerings
7.7.4 MultiVir Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.7.5 MultiVir Key News
7.8 SynerGene Therapeutics
7.8.1 SynerGene Therapeutics Corporate Summary
7.8.2 SynerGene Therapeutics Business Overview
7.8.3 SynerGene Therapeutics Gene Therapies for Cancer Treatment Major Product Offerings
7.8.4 SynerGene Therapeutics Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.8.5 SynerGene Therapeutics Key News
7.9 Ziopharm Oncology
7.9.1 Ziopharm Oncology Corporate Summary
7.9.2 Ziopharm Oncology Business Overview
7.9.3 Ziopharm Oncology Gene Therapies for Cancer Treatment Major Product Offerings
7.9.4 Ziopharm Oncology Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.9.5 Ziopharm Oncology Key News
7.10 Anchiano Therapeutics
7.10.1 Anchiano Therapeutics Corporate Summary
7.10.2 Anchiano Therapeutics Business Overview
7.10.3 Anchiano Therapeutics Gene Therapies for Cancer Treatment Major Product Offerings
7.10.4 Anchiano Therapeutics Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.10.5 Anchiano Therapeutics Key News
7.11 Celgene
7.11.1 Celgene Corporate Summary
7.11.2 Celgene Business Overview
7.11.3 Celgene Gene Therapies for Cancer Treatment Major Product Offerings
7.11.4 Celgene Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.11.5 Celgene Key News
7.12 Celsion
7.12.1 Celsion Corporate Summary
7.12.2 Celsion Business Overview
7.12.3 Celsion Gene Therapies for Cancer Treatment Major Product Offerings
7.12.4 Celsion Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.12.5 Celsion Key News
7.13 Bluebird Bio
7.13.1 Bluebird Bio Corporate Summary
7.13.2 Bluebird Bio Business Overview
7.13.3 Bluebird Bio Gene Therapies for Cancer Treatment Major Product Offerings
7.13.4 Bluebird Bio Gene Therapies for Cancer Treatment Revenue in Global Market (2017-2022)
7.13.5 Bluebird Bio Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
